We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLRC:NASDAQSLR Investment Corp. Analysis

Data as of 2026-08-02 - not real-time

$12.58

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

SLR Investment Corp. (SLRC) is trading at $12.58, well below its 20‑day and 50‑day SMAs (12.94 and 12.83) and the 200‑day SMA (14.47), with a bearish MACD histogram and an RSI of 41.5, suggesting short‑term downside pressure toward the identified support at $12.35. However, the stock offers a substantial upside potential of roughly 22% to the analyst consensus target around $15.5, supported by a low beta (0.53) that moderates market‑wide volatility exposure.
Fundamentally, SLRC appears markedly undervalued – its trailing P/E of 7.7 is less than half the industry average of 18.0, and its price‑to‑book of 0.69 sits below the $1 benchmark. The dividend yield is exceptionally high at 12.23%, but the 100% payout ratio and negative operating cash flow (-$72.9 M) raise concerns about sustainability. The balance sheet is leveraged, with a debt‑to‑equity of 115% and $1.14 B of debt versus $400 M of cash, contributing to a max drawdown of –27% over the recent period. Recent news highlights stable net interest income and NAV per share in Q4 2025, indicating resilience in a challenging private‑credit environment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above the $12.35 support level
  • Bearish MACD and RSI below 50 indicating limited near‑term upside
  • High dividend yield but sustainability concerns

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap (P/E 7.7 vs industry 18.0, P/B 0.69)
  • Analyst consensus target around $15.5 implies ~22% upside
  • Low beta reduces market‑wide volatility exposure

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Elevated leverage (Debt/Equity 115%) and negative cash flow
  • Dividend payout at 100% of earnings may pressure future distributions
  • Business‑development‑company structure provides steady income but depends on credit market conditions

Key Metrics & Analysis

Financial Health

Revenue Growth-7.30%
Profit Margin41.80%
P/E Ratio7.7
ROE9.06%
ROA3.75%
Debt/Equity114.88
P/B Ratio0.7
Op. Cash Flow$-72972000
Free Cash Flow$-4630875
Industry P/E18.0

Technical Analysis

TrendNeutral
RSI41.5
Support$12.35
Resistance$13.37
MA 20$12.94
MA 50$12.83
MA 200$14.47
MACDBearish
VolumeStable
Fear & Greed Index92.88

Valuation

Target Price$15.38
Upside/Downside22.22%
GradeUndervalued
TypeValue
Dividend Yield12.23%

Risk Assessment

Beta0.53
Volatility22.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.